EOLO-42016

N/A

Report date: 2025/01/26 19:24:44
NME

Base Information

Drug NameEOLO-42016
Drug Alias Nameelectrophilic drugs (EOLO pharma)EOLO-42016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryArgentina
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEOLO Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEOLO Pharma
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A